
    
      Non-interventional, open-label, single group, multicentric post-marketing surveillance to
      monitor the safety and effectiveness of Topotecan administered in Korean patients according
      to the prescribing information

      Topotecan will be administered as described the prescribing information or by physician's
      decision.
    
  